Last reviewed · How we verify
misprostol
At a glance
| Generic name | misprostol |
|---|---|
| Also known as | Cytotec |
| Sponsor | Gynuity Health Projects |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Preventing Postpartum Hemorrhage: Examining Two Strategies for PPH Prevention in Communities: Misoprostol and Oxytocin in UnijectTM in Mali (NA)
- Letrozole and Misoprostol for Early Pregnancy Loss Management: A Prospective Pilot Cohort Study (Phase 2)
- The Misoprostol Vaginal Insert Compared With Oral Misoprostol for Labour Induction in Term Pregnancies: a Pair-matched Case-control Study (N/A)
- A Randomized Control Trial of Combined Vaginal Misoprostol and Perivascular Vasopressin During Robotic Myomectomy (Phase 4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- misprostol CI brief — competitive landscape report
- misprostol updates RSS · CI watch RSS
- Gynuity Health Projects portfolio CI